This article addresses the critical sterility assurance challenges faced by researchers and drug development professionals in the manufacturing of Advanced Therapy Medicinal Products (ATMPs).
This article provides a comprehensive comparative analysis of the three primary 3D bioprinting technologies—inkjet, extrusion, and laser-assisted—with a focused examination of their printing resolution, a critical parameter for biomedical research...
This article provides a systematic guide for researchers and drug development professionals tackling nozzle clogging, a major bottleneck in the bioprinting of high-cell-density constructs essential for creating physiologically relevant tissue...
In situ bioprinting represents a paradigm shift in regenerative medicine, enabling the direct deposition of cells and biomaterials into defect sites during surgical procedures.
This article explores the transformative potential of omnidirectional 3D bioprinting, a suite of advanced fabrication techniques that overcome the limitations of traditional layer-by-layer manufacturing.
This article comprehensively reviews intramyocardial injection as a targeted strategy for local paracrine delivery in cardiac repair.
This article provides a comprehensive evaluation of methods for preserving and verifying cellular identity, a critical challenge in cell-based therapies and single-cell genomics.
This article details the PureCap method, a groundbreaking technological advancement that enables the purification of completely capped mRNA with near-100% efficiency.
This article provides a comprehensive guide for researchers and drug development professionals on managing batch variation in autologous cell products.
Allogeneic cell therapies derived from healthy donors or induced pluripotent stem cells (iPSCs) offer transformative potential for treating cancer, diabetes, and autoimmune diseases by providing 'off-the-shelf' availability.